Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|March 16, 2011
RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in miceStephen A McCartney, William Vermi, Silvia Lonardi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2023
Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 StudiesGarrett R Mullins, Michael E Hodsdon, Ying Grace Li, et al.
The Journal of Applied Laboratory Medicine|July 20, 2023
A Monovalent Fab Affinity-Capture and Elution Bridging Immunoassay Overcomes Rheumatoid Factor Interference while Accurately Detecting Antidrug AntibodiesBoris Calderon, Nichole A Reynolds, Craig A Swearingen, et al.
The Journal of Experimental Medicine|September 9, 2015
The pancreas anatomy conditions the origin and properties of resident macrophagesBoris Calderon, Javier A Carrero, Stephen T Ferris, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cellsAnthony N Vomund, Bernd H Zinselmeyer, Jing Hughes, et al.
Diabetes|July 10, 2013
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet functionS Armando Villalta, Jiena Lang, Samantha Kubeck, et al.
Elife|April 1, 2017
A type I IFN-dependent DNA damage response regulates the genetic program and inflammasome activation in macrophagesAbigail J Morales, Javier A Carrero, Putzer J Hung, et al.
Mabs|May 18, 2019
Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity riskNicoletta Bivi, Terry Moore, George Rodgers, et al.
Science (New York, N.Y.)|November 15, 2008
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunityKai Hildner, Brian T Edelson, Whitney E Purtha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2021
Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid TumorsMatthew D Hellmann, Nicoletta Bivi, Boris Calderon, et al.
Pageof 4